Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “modified”

433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 433
Index total 30,257
Page 13 / 19

Quick answer

This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

433 results for “modified” · 30,257 patents in full index Clear search

  1. US 9043996

    Genetically modified major histocompatibility complex animals

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  2. US 9034318

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted May 19, 2015 · Expires May 14, 2035

    granted

  3. US 9012647

    Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  4. US 9012618

    Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  5. US 9005599

    Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

    Tissue Regeneration Therapeutics Inc. · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  6. US 9005648

    Inorganically surface-modified polymers and methods for making and using them

    The Regents of the University of California · Granted Apr 14, 2015 · Expires Apr 9, 2035

    granted

  7. US 8916172

    MVA expressing modified HIV envelope, gag, and pol genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  8. US 8852576

    Modified sodium iodide symporter proteins and uses thereof

    China Medical University · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

  9. US 8835505

    Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container

    Welgrace Research Group · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  10. US 8829054

    Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container

    Welgrace Research Group · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  11. US 8821930

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  12. US 8809016

    Nucleic acids encoding modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  13. US 8796436

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  14. US 8779128

    Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

    Sarepta Therapeutics, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  15. US 8778870

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  16. US 8772256

    Codon modified immunogenic compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  17. US 8741345

    Modified release pharmaceutical compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  18. US 8692052

    Genetically modified mice and engraftment

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  19. US 8691241

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  20. US 8658648

    Modified chloroquines with single ring moiety or fused ring moiety

    DesignMedix, Inc. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  21. US 8642738

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  22. US 8628769

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  23. US 8617600

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  24. US 8609607

    Modified defensins and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.